Securities Code: 300723
Securities Abbreviation: Yipin Red
Announcement No.: 2026-045
Yipin Red Pharmaceutical Group Co., Ltd.
Announcement on Wholly-Owned Subsidiary Obtaining Benzbromarone Tablets Registration Certificate
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or significant omissions.
Yipin Red Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company") announces that its wholly-owned subsidiary, Guangzhou Yipin Red Pharmaceutical Co., Ltd., recently received a "Drug Registration Certificate" for Benzbromarone Tablets issued by the National Medical Products Administration. The relevant matters are hereby announced as follows:
I. Main Information of the Drug Registration Certificate